Most secondary buyers focus on price. They benchmark the implied valuation against the last primary round, check the liquidation preference stack, and decide whether the discount is wide enough. Anti-dilution provisions rarely enter the conversation — which is a mistake, because those provisions can meaningfully change your economic outcome at exit.
What anti-dilution protection actually does
Anti-dilution protection adjusts the conversion ratio of preferred shares into common when a company raises new money at a lower price per share than the price paid by earlier investors. In plain terms: if you hold Series B preferred at a $50 implied price and the company later raises a Series C at $30, an anti-dilution provision gives you more common shares on conversion to partially compensate for the loss in value.
There are two main flavors. Full-ratchet anti-dilution resets your conversion price to whatever the new low-water price is — the harshest protection for the company, most generous to you. Weighted-average anti-dilution blends the old and new prices, weighted by the number of shares issued, giving a more moderate adjustment. Virtually every institutional venture deal written after 2005 uses weighted-average, not full-ratchet.
Secondary buyers inherit whatever flavor is written into the original preferred stock purchase agreement (SPA) and certificate of incorporation. You are not negotiating these terms — they are fixed. The question is whether you have read them.
The three scenarios where this actually matters
Scenario 1: A down round before exit
Down rounds are not theoretical. Several late-stage private companies have repriced significantly from their 2021 peaks. If you purchased Series C preferred at an implied $80 per share and the company raises a bridge at $40, your weighted-average anti-dilution provision will adjust your conversion ratio upward. You do not get new cash, but you receive more common shares per preferred share at conversion — partially offsetting the valuation drop.
The catch: this protection only applies if you hold preferred shares. If you bought common shares — often the case for employee equity sold on the secondary market — you have no anti-dilution protection at all. Common shares dilute at face value with every new issuance.
Scenario 2: Pay-to-play clauses attached to anti-dilution rights
Many preferred stock certificates include pay-to-play provisions alongside anti-dilution rights. These require existing preferred holders to participate pro rata in a down round to keep their anti-dilution protection. If you, as a secondary holder, cannot or choose not to participate in a future round, you may forfeit your anti-dilution rights and see your preferred shares converted to common — losing the preference stack entirely.
Secondary buyers rarely have the right to participate in future primary rounds. You are purchasing an existing position; pro-rata rights typically belong to the original investor and are not transferred automatically. Check the transfer documents and the original SPA to confirm whether pro-rata rights were assigned. If they were not, a pay-to-play clause is a latent risk embedded in your position.
Scenario 3: Conversion at IPO
At IPO, preferred shares convert to common. If anti-dilution adjustments have accumulated — because of prior down rounds or repricing events — your conversion ratio may already be above 1:1. That means each preferred share you hold converts into more than one common share, and your effective cost basis per common share is lower than the face price you paid. This is genuinely favorable — but only if you understood you had that protection going in.
What to verify before you transact
Secondary diligence on anti-dilution provisions is straightforward once you know what to look for. The relevant documents are the company's certificate of incorporation (which defines the conversion mechanics) and the original preferred stock purchase agreement or series term sheet (which may add pay-to-play and other conditions).
- Confirm which share class you are buying — preferred versus common changes your protection entirely.
- Identify whether the certificate uses broad-based or narrow-based weighted average, or the rarer full-ratchet.
- Check for pay-to-play language and whether pro-rata rights transferred to you as secondary buyer.
- Look for any carve-outs that exclude certain issuances from the anti-dilution calculation — employee option pool expansions, for example, are commonly excluded.
- Ask whether any prior anti-dilution adjustments have already modified the current conversion ratio from the original 1:1.
Not all of this information will be available to every secondary buyer. Private companies are not required to disclose cap table details to secondary investors, and information rights are rarely transferred in secondary transactions. What you can do is ask your marketplace or broker to confirm the share class and request whatever capitalization certificate or investor letter the seller can provide.
How SPV structures interact with anti-dilution
If you are buying through an SPV rather than taking a direct transfer of shares, the SPV holds the underlying preferred shares and you hold a membership interest in the SPV. Your economic exposure to anti-dilution adjustments flows through the SPV — you benefit from the adjusted conversion ratio at exit, but you have no direct relationship with the company's cap table.
This matters because the SPV manager controls the conversion decision at IPO or acquisition. Most well-drafted SPV agreements require the manager to convert on the same terms as the underlying shares, passing through any anti-dilution benefit. Read the waterfall section of the operating agreement to confirm this is explicit, not assumed. A poorly drafted SPV can strip you of benefits the original preferred holder would have received.
At Limen Markets, SPV operating agreements are templated and reviewed to ensure that anti-dilution conversion benefits pass through to members on the same economic terms as the underlying position. Buyers can review the operating agreement before committing to any indication of interest.
The common stock caveat
A large portion of secondary supply comes from employees selling vested equity — restricted stock units (RSUs), exercised ISOs, or NQSOs converted to common shares. Common stock carries no anti-dilution protection, no liquidation preference, and no conversion ratio mechanics. What you get is pure economic exposure to the company's per-share value at exit after all preferred liquidation preferences are satisfied.
That is not inherently bad — common can deliver strong returns in an up-exit scenario. But you need to price it correctly relative to preferred. Paying a preferred-equivalent price for common shares ignores the structural disadvantage you are accepting.
Our guide to preferred versus common secondary economics walks through the discount framework in detail. If you are looking at a specific position on the marketplace and want to understand which share class underlies the listing, the deal page will specify this before you submit an indication of interest.
Browse current listings at /marketplace, or read the preferred versus common economics guide before you place your next indication.